61
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Cytokine Profile and Natural Killer Cell Activity in Listeria Monocytogenes Infected Mice Treated Orally with Petiveria Alliacea Extract

, &
Pages 501-518 | Published online: 27 Sep 2008

References

  • Germano D. H.P., Caldeira T. T.O., Mazella A. A.G., Sertié J. A.A., Bacchi E. M. Topical anti-inflammatory activity and toxicity of. Petiveria alliacea. Fitoterapia 1993; LXIV: 459–462
  • Rossi V., Jovicevic L., Troiani M. P., Bonanomi M., Mazzanti G. Antiproliferative effects of Petiveria alliacea on several tumor cell lines. Pharmacological Research 1990; 22: 434
  • Rossi V., Marini S., Jovicevic L., D'Atri S., Turri M., Giardina B. Effects of Petiveria alliacea L. on cell immunity. Pharmacological Research 1993; 27: 111–112
  • Quadros M. R., Souza Brito A. R.M., Queiroz M. L.S. Petiveria alliacea L. extract protects mice against Listeria monocytogenes infection-effects on bone marrow progenitor cells. Immunopharm. Immunotoxicol. 1999; 21: 109–124
  • Bancroft G. J. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 1993; 5: 503–510
  • Ladel C. H., Blum C., Kaufmann S. H.E. - Control of natural killer cell-mediated innate resistance against the intracellular pathogen Listeria monocytogenes by γ/δ lymphocytes. Infection and Immunity 1996; 64: 1744–1749
  • Ferrick D. A., Schrenzel M. D., Mulvania T., Hsieh B., Ferlin W. G., Lepper H. Differential production of interferon-γ and interleukin-4 in response to Th1 and Th2-stimulating pathogen by γδ T cells in vivo. Nature (London) 1995; 373: 255–257
  • Nakane A., Numata A., Asano M., Kohanawa M., Chen Y., Minagawa T. Evidence that endogenous gamma interferon is produced early in Listeria monocytogenes infection. Infect. Immun. 1990; 58: 2386–2388
  • Nakane A., Numata A., Minagawa T. Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect. Immun. 1992; 60: 523–528
  • Buchmeier N. A., Schreiber R. D. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc. Acad. Natl. Sci. USA 1985; 82: 7404–7408
  • Harty J. T., Bevan M. J. Specific immunity to Listeria monocytogenes in the absence of IFN-γ. Immunity 1995; 3: 109–117
  • Tsukada H., Kawamura I., Arakawa M., Nomoto K., Mitsuyama M. Dissociated development of T cells against Listeria monocytogenes and their functional difference in lymphokine production. Infect. Immun. 1991; 59: 3589–3595
  • Xiong H., Nishtbori T., Ohya S., Tanabe Y., Mitsuyama M. Involvement of various combinations of endogenous inflammatory cytokines in Listeria monocytogenes-induced expression of inducible nitric oxide syntase in mice. FEMS Immunol. Med. Microbiol 1996; 16: 257–266
  • Haak-Frendscho M;, Brown J. F., Iizawa Y., Wagner R. D., Czuprynski C. J. An administration of anti-IL-4 antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J Immmunol. 1992; 148: 3978–3985
  • Tripp C. S., Beckerman K. P., Unanue E. R. Immune complexes inhibit antimicrobial responses through interleukin-10 production: effects in severe combined immunodeficient mice during Listeria infection. J. Clin. Invest. 1995; 95: 1628–1634
  • Donahue J. H., Rosenberg S. A. The fate of interleukin-2 after administration in vivo. J. Immunol. 1983; 130: 2203–2208
  • Hefeneiden S. H., Conlon P. J., Henney C. S., Gillis S. In vivo interleukin-2 administration augments the generation of alloreactive cytolitic T lymphocytes and resident natural killer cells. J. Immunol. 1983; 130: 222–227
  • Farrar W. L., Johnson H. M., Farrar J. J. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J. Immun. 1981; 126: 1120–1125
  • Chong K. T. Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria. Infect. Immunol. 1987; 55: 668–673
  • Zinkernagel R. M., Althage A., Adler B., Blandem R. V., Davidson W. F., Kees U., Dunlop M. B.C., Shreffler D. C. H-2 restriction of cell mediated immunity to an intracellular bacterium. Effector T cells are specific for Listeria antigen self-markers. J. Exp. Med. 1977; 145: 1353–1367
  • Haak-Frendscho M., Young K. M., Czuprynski C. J. Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen. Listeria monocytogenes. Infect. Immmun. 1989; 57: 3014–3021
  • Yap S. G., Sher A. Effector cells of both nonhematopoietic and hematopoietic origin are required for Interferon (IFN)-γ- and Tumor Necrosis Factor (TNF)-α- dependent host resistance to the intracellular pathogen. Toxoplasma gondii. J. Exp. Med. 1999; 189: 1083–1091
  • Smith K. A. Interleukin-2: inception, impact, and implications. Science 1988; 240: 1169–1176
  • Tripp C. S., Wolf S. F., Unanue E. R. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 1993; 90: 3725–3729
  • Limb G. A., Meager A., Wooley J., Wadhwa M., Biggerstaff J., Brown K. A., Wolstencroft. Release of cytokines during generation of lymphokine-activated killer (Lak) cells by Il-2. Immunol. 1989; 68: 514–519
  • Dunn D. L., North R. J. Early gamma interferon production by natural killer cells important in defense against murine listeriosis. Infect. Immun. 1991; 59: 2892–2900
  • Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 1991; 132: 150–157
  • Brunt L. M., Portnoy D. A., Unanue E. R. Presentation of Listeria monocytogenes to Cd8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J. Immunol 1990; 145: 3540–3546
  • Kinderlen A. F., Kaufmann S. H.E., Lohmann-Matthes M. L. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur. J. Immunol 1984; 14: 964–967
  • Scharton T. M., Scott E. R. Natural killer cells are a source of interferon y that drives differentiation of Cd4+ cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 1993; 178: 567–577
  • Dorshkind K., Pollack S. B., Bosma M. J., Phillips R. A. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J. Immunol 1985; 134: 3798–3801
  • Bancroft G. J., Schreiber R. D., Bosma G. C., Bosma M. J., Unanue E. R. A T-cell-independent mechanism of macrophage activation by interferon-γ. J. Immunol 1987; 139: 1104–1107
  • Kaye P. M., Bancroft G. J. Leishmania donovani infection in Scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect. Immun. 1992; 60: 4335
  • Kelly J. P., Bancroft G. J. Administration of interleukin-10 abolishes innate resistance to. Listeria monocytogenes. Eur. J. Immunol 1996; 26: 356–364
  • Mosmann T. R. Proprierties and functions of interleukin-10. Adv. Immunol 1994; 56: 1–26
  • Mielke M. E. A., Ehlers S, Hahn H. The role of cytokines in experimental listeriosis. Immunobiol. 1993; 189: 285–315

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.